Finance

Lists
CERS:NASDAQ
Cerus Corp
$2.19
+1.86%
(+0.040) 1D
$2.22
+1.37% (+0.030)
After hours
Closed: Aug 4, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CERS...
Open
$2.13
High
$2.22
Low
$2.06
Mkt. cap
441.34M
Avg. vol.
2.84M
Volume
0.00
52-wk high
$3.47
52-wk low
$1.15
EPS
-$0.03
Beta
1.81
Shares outstanding
201.52M
No. of employees
268
Open
$2.13
High
$2.22
Low
$2.06
Mkt. cap
441.34M
Avg. vol.
2.84M
Volume
0.00
52-wk high
$3.47
52-wk low
$1.15
EPS
-$0.03
Beta
1.81
Shares outstanding
201.52M
No. of employees
268
News stories
From sources across the web
Profile
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
About Cerus Corp
CEO-
Employees268
FoundedSep 1991
HeadquartersConcord, California, United States
SectorMedical device
Websitecerus.com
Analyst ratings
Based on 1 analyst giving stock ratings to CERS in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for CERS in the last 3 months
Highest
Current $2.19
$5.00 (+128.31%)
Average
$5.00 (+128.31%)
Lowest
$5.00 (+128.31%)
Analyst
Recommendation
Action
Price target
Projected
Date
Josh Jennings
TD Cowen
Buy
Reiterated
$5.00
+128.3%
07/31/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
05/01/2026
Mark Massaro
BTIG
Buy
Upgraded
$4.00
+82.6%
05/01/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
52.70M
57.75M
53.66M
57.44M
Cost of goods sold
24.56M
28.00M
25.77M
27.91M
Cost of revenue
24.56M
28.00M
25.77M
27.91M
Research and development expenses
15.82M
16.39M
14.53M
14.39M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.62M
20.83M
19.95M
22.86M
Operating expense
26.90M
30.39M
28.25M
31.39M
Total operating expenses
51.46M
58.39M
54.02M
59.30M
Operating income
1.24M
-641.00K
-354.00K
-1.86M
Other non operating income
976.00K
578.00K
520.00K
734.00K
EBT including unusual items
65.00K
-2.06M
-1.56M
-2.89M
EBT excluding unusual items
65.00K
-2.08M
-1.56M
-2.89M
Income tax expense
85.00K
119.00K
91.00K
95.00K
Effective tax rate
130.77%
-5.76%
-5.84%
-3.29%
Other operating expenses
-7.54M
-6.83M
-6.23M
-5.86M
Net income
-19.00K
-2.18M
-1.64M
-2.94M
Net profit margin
-0.04%
-3.78%
-3.06%
-5.12%
Earnings per share
-
-0.01
-0.01
-0.01
Interest and investment income
-
-
-
-
Interest expense
-2.12M
-1.96M
-1.87M
-1.71M
Net interest expenses
-2.12M
-1.96M
-1.87M
-1.71M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.62M
-248.00K
93.00K
-1.40M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps